MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.

Institutional investor · Portfolio as of Q3 2025

SEC EDGAR SourceSEC Filings

Top Holdings134 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2.8M$1.5B7.5%$228.73+124.56%
27 qtrssince 2019-Q1
Unchanged
0

APPLE INC

4.8M$1.2B6.2%$147.16+72.39%
27 qtrssince 2019-Q1
Increased
62

NVIDIA CORP

6.4M$1.2B6.1%$118.82+53.04%
27 qtrssince 2019-Q1
Unchanged
0

ALPHABET INC-CL A

4.8M$1.2B5.9%$105.49+131.19%
27 qtrssince 2019-Q1
Increased
64
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

38.9M$786.2M4.0%$11.46+67.39%
24 qtrssince 2019-Q4
Increased
59

AMAZON.COM INC

3.4M$745.2M3.8%$137.40+61.70%
27 qtrssince 2019-Q1
Increased
58

META PLATFORMS INC-CLASS A

866,465$636.3M3.2%$273.44+171.65%
22 qtrssince 2020-Q2
Decreased
0

BROADCOM INC

1.7M$574.2M2.9%$217.61+50.39%
4 qtrssince 2024-Q4
Unchanged
0
XLIXLI
ETF

INDUSTRIAL SELECT SECT SPDR

3.5M$544.3M2.8%$137.54+10.90%
8 qtrssince 2023-Q4
Increased
75

JPMORGAN CHASE & CO

1.5M$467.5M2.4%$146.85+112.97%
9 qtrssince 2023-Q3
Unchanged
0

MASTERCARD INC - A

690,560$392.8M2.0%$341.32+65.98%
19 qtrssince 2021-Q1
Increased
49

TESLA INC

860,781$382.8M1.9%$282.32+56.99%
10 qtrssince 2023-Q2
Increased
55

NOVA LTD

1.2M$372.5M1.9%$49.23+531.92%
27 qtrssince 2019-Q1
Decreased
0
FLINFLIN
ETF

FRANKLIN TEMPLETON ETF TR

9.3M$347.9M1.8%$33.47+11.07%
10 qtrssince 2023-Q2
Unchanged
0

APPLIED MATERIALS INC

1.7M$347.6M1.8%$122.54+66.35%
19 qtrssince 2021-Q1
Increased
49
XLEXLE
ETF

ENERGY SELECT SECTOR SPDR

3.6M$322.5M1.6%$44.24+1.21%
11 qtrssince 2023-Q1
Increased
59
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

1.1M$306.3M1.6%$94.09+189.61%
12 qtrssince 2022-Q4
Unchanged
0

BERKSHIRE HATHAWAY INC-CL B

573,501$288.3M1.5%$415.08+20.28%
8 qtrssince 2023-Q4
Increased
61
XLUXLU
ETF

UTILITIES SELECT SECTOR SPDR

3.2M$279.3M1.4%$38.12+13.36%
11 qtrssince 2023-Q1
Increased
49
XLPXLP
ETF

CONSUMER STAPLES SPDR

3.3M$260.1M1.3%$76.33+1.52%
11 qtrssince 2023-Q1
Decreased
0
$19.7B
AUM
134
Positions
Q3 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
+10%Q2'24$14.7B+8%Q3'24$15.9B+1%Q4'24$16B-3%Q1'25$15.4B+13%Q2'25$17.4B+13%Q3'25$19.7B
Activity profile
$ moved · Q3'25
New10%Increased64%Decreased17%Exited9%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q7%1-4Q26%1-2Y9%2Y+57%

MENORA MIVTACHIM HOLDINGS LTD. manages $19.7B across 134 positions as of Q3 2025. Top holdings: MSFT (7.5%), AAPL (6.2%), NVDA (6.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q3 2025 Summary

Active quarter - 16 new positions, 13 exits, 42 increased. Top move: XLI (INCREASED, conviction 75). Portfolio: $19.7B across 134 positions.

Top holdings by portfolio weight

Total AUM$20B
MSFT7.48%
AAPL6.18%
NVDA6.10%
GOOGL5.90%
TEVA3.99%
AMZN3.78%
META3.23%
AVGO2.92%
XLI2.76%
JPM2.37%
Other1.99%

Portfolio allocation by GICS sector

Sectors11
Technology34.74%
Unknown21.38%
Communication Services9.58%
Healthcare9.51%
Financial Services9.14%
Consumer Cyclical8.04%
Consumer Defensive3.34%
Industrials2.09%
Real Estate1.68%
Energy0.27%
Other0.23%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record52
Conviction45
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TEVATEVATEVA PHARMACEUTICAL-SP ADR
Q1 2025 Q2 2026+11.5M shares+$724.7M
5Q
KREKRESPDR SERIES TRUST
Q2 2025 Q2 2026+3.3M shares+$248M
4Q
QQQQQQINVESCO QQQ TRUST SERIES 1 CL USD INC
Q3 2025 Q2 2026+10,060 shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used